MENU
RYOIX
Mutual Fund ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

Rydex Biotechnology I (RYOIX) Ownership - Who owns Rydex Biotechnology I?

The investment seeks to provide capital appreciation... Show more

Category: #Health

Profile

Category
Health
Address
Rydex Series Funds9601 Blackwell Road,Suite 500Rockville
Phone
N/A
Web
www.rydex-sgi.com

Details

Group
Domestic Stock Funds
Category
Health
Total Expense Ratio
1.40
Min. Initial Investment
2500.00
Fund Existence
over 27 years
Turnover
79.00
Front Load
N/A
Net Assets
84275170.00
Manager Tenure
N/A

Fundamentals

RYOIX
Net Assets
84.3M
Fund Existence
over 27 years
Turnover
79.00
Total Expense Ratio
1.40
Front Load
N/A
Manager
N/A
Manager Tenure
N/A
Min. Initial Investment
2500
Min. Initial Investment IRA
N/A
Morningstar Category
Health
Administrative Fee
N/A
Annual Report Gross Expense Ratio
1.43
Assets in Top Ten Holdings
46.1M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
67.3M
Fund Type
OpenEnd
Index Fund
No
Management Fee
0.85
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
79.00
Number of Net Holdings
81.00
Number of Short Holdings
2.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
38.25%
Gain YTD
2.605
Annual Yield % from dividends
0.00
Returns for 1 year
-13.95
Returns for 3 years
-9.24
Returns for 5 years
-28.56
Returns for 10 years
-34.03
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the mutual fund lost 0.00%.
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Rydex Series Funds9601 Blackwell Road,Suite 500Rockville
Phone
N/A
Web
www.rydex-sgi.com